Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78.8M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
22.9M
-
Shares change
-
+3.69M
-
Total reported value, excl. options
-
$185M
-
Value change
-
+$30M
-
Put/Call ratio
-
0.67
-
Number of buys
-
84
-
Number of sells
-
-32
-
Price
-
$8.10
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q4 2024
143 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q4 2024.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.9M shares
of 78.8M outstanding shares and own 29.06% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (4.57M shares), VANGUARD GROUP INC (3.38M shares), Elliott Investment Management L.P. (2.87M shares), STATE STREET CORP (1.45M shares), GEODE CAPITAL MANAGEMENT, LLC (1.39M shares), First Turn Management, LLC (1.02M shares), NORTHERN TRUST CORP (512K shares), J. Goldman & Co LP (457K shares), D. E. Shaw & Co., Inc. (446K shares), and MORGAN STANLEY (399K shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.